The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

Clinical trial NCT05689710 · SUSPENDED

Trial details

NCT number: NCT05689710
Sponsor: Lo.Li.Pharma s.r.l
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metabolic Syndrome Cardiac Fibrosis

Start date: 2022-12-23
Primary completion: 2026-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.